Overview

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
0
Participant gender:
Female
Summary
The primary outcome of this study is to assess if the GnRHa administration before cold loop hysteroscopic myomectomy contributes to accomplish the treatment in only one surgical procedure. Moreover, we will investigate the intraoperative influence of such pharmacologic therapy in terms of distension liquid absorption and duration of the procedures.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Azienda Ospedaliera S. Maria della Misericordia
Treatments:
Deslorelin
Triptorelin Pamoate
Criteria
Inclusion Criteria:

- submucous myoma diagnosed by vaginal ultrasonography and confirmed by diagnostic
hysteroscopy

- premenopausal status

Exclusion Criteria:

- present or past history of cancer

- pregnancy

- presence of associated multiple polyps

- presence of > 2 myomas

- associated nonhysteroscopic surgical procedures